From one disease to several diseases: a new approach of the pathophysiology of osteoarthritis

被引:2
作者
Sellam, Jeremie [1 ]
机构
[1] Sorbonne Univ, Hop St Antoine, AP HP,Inserm UMRS 938, Serv Rhumatol,CRSA,Dept Hosp Univ Inflammat Immun, 184 Rue Faubourg St Antoine, F-75012 Paris, France
来源
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2018年 / 202卷 / 1-2期
关键词
OSTEOARTHRITIS; PHYSIOLOGY; PHENOTYPE; OF-THE-ART; KNEE OSTEOARTHRITIS; METABOLIC SYNDROME; DIABETES-MELLITUS; PERSPECTIVES; INFLAMMATION; PREVALENCE; SYNOVITIS; CARTILAGE; SYMPTOMS;
D O I
10.1016/S0001-4079(19)30347-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoarthritis (OA) is the most common osteoarticular disease associated with excess mortality due to functional disability. Its physiopathology has made great progress in recent years with a thorough knowledge of the role of each joint tissue, beyond the single involvement of cartilage. The role of each tissue (cartilage, synovium and subchondral bone) and their interactions in the mechanisms of joint degradation has been better understood. Three major clinical phenotypes of OA are clinically defined based on its main risk factors: post-traumatic OA, metabolic OA including obesity-related OA and aging-related OA. Another approach is to study the pathophysiology of OA according to these phenotypes, assuming that each phenotype has pathophysiological specificities. Since these tissue lesions or phenotypes can easily be characterized clinically or by modern imaging methods, we can imagine for the future personalized and targeted treatments resulting from these new pathophysiological data.
引用
收藏
页码:139 / 149
页数:11
相关论文
共 50 条
  • [21] Osteoarthritis Increases the Risk of Cardiovascular Disease: Data from the Osteoarthritis Initiative
    Veronese, N.
    Stubbs, B.
    Solmi, M.
    Smith, T. O.
    Reginster, J-Y.
    Maggi, S.
    JOURNAL OF NUTRITION HEALTH & AGING, 2018, 22 (03) : 371 - 376
  • [23] Blinding images to sequence in osteoarthritis: evidence from other diseases
    Felson, D. T.
    Nevitt, M. C.
    OSTEOARTHRITIS AND CARTILAGE, 2009, 17 (03) : 281 - 283
  • [24] How can one develop disease-modifying drugs in osteoarthritis?
    Dougados M.
    Current Rheumatology Reports, 2005, 7 (1) : 22 - 28
  • [25] Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease
    Roos, Cornelis J.
    Quax, Paul H. A.
    Jukema, J. Wouter
    BIOMARKERS IN MEDICINE, 2012, 6 (01) : 35 - 52
  • [26] The Role of Vitamin K in Chronic Aging Diseases: Inflammation, Cardiovascular Disease, and Osteoarthritis
    Harshman S.G.
    Shea M.K.
    Current Nutrition Reports, 2016, 5 (2) : 90 - 98
  • [27] OSTEOARTHRITIS AS AN ORGAN DISEASE: FROM THE CRADLE TO THE GRAVE
    Aspden, R. M.
    Saunders, F. R.
    EUROPEAN CELLS & MATERIALS, 2019, 37 : 74 - 87
  • [28] Natural history of new horizontal meniscal tears in individuals at risk for and with mild to moderate osteoarthritis: data from osteoarthritis initiative
    Posadzy, Magdalena
    Joseph, Gabby B.
    McCulloch, Charles E.
    Nevitt, Michael C.
    Lynch, John A.
    Lane, Nancy E.
    Link, Thomas M.
    EUROPEAN RADIOLOGY, 2020, 30 (11) : 5971 - 5980
  • [29] Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease
    Frak, Weronika
    Wojtasinska, Armanda
    Lisinska, Wiktoria
    Mlynarska, Ewelina
    Franczyk, Beata
    Rysz, Jacek
    BIOMEDICINES, 2022, 10 (08)
  • [30] The Cost of a Commute: A Multidisciplinary Approach to Osteoarthritis in New Kingdom Egypt
    Austin, A. E.
    INTERNATIONAL JOURNAL OF OSTEOARCHAEOLOGY, 2017, 27 (04) : 537 - 550